Current concepts in gene therapy of the musculoskeletal system;Současné názory na genovou terapii pohybového systému

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

Volumn 73, Issue 2, 2006, Pages 115-122

  Ivković, Alan ^a   Pascher, A ^b   Hudetz, D ^c   Jelic M ^a   Haspl M ^a   Windhager, R ^b   Pecina M ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c KBC Zagreb   (Croatia)

Author keywords

Bone; Cartilage; Gene therapy; Musculoskeletal system; Regeneration; Repair; Rheumatoid arthritis

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; DECORIN; DNA; EPIDERMAL GROWTH FACTOR; ETANERCEPT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 4; NAKED DNA; NERVE GROWTH FACTOR; OSTEOGENIC PROTEIN 1; OSTEOPROTEGERIN; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; VIRUS VECTOR;

BONE REGENERATION; CARTILAGE; CLINICAL PROTOCOL; DRUG EFFICACY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; INTERVERTEBRAL DISK; KNEE MENISCUS; LIGAMENT; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PROSTHESIS LOOSENING; REVIEW; RHEUMATOID ARTHRITIS; TENDON; TISSUE REPAIR; TUMOR;

GENE THERAPY; GENETIC VECTORS; GROWTH SUBSTANCES; HUMANS; MUSCULOSKELETAL DISEASES;

EID: 33646424798     PISSN: 00015415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. BALTZER, A. W, WHALEN, J. D., WOOLEY, P., LATIERMAN, C., TRUCHAN, L. M., ROBBINS, P. D. et al.: Gene therapy for osteoporosis: evaluation in a murine ovariectomy model. Gene Ther., 8:1770-1776, 2001.
2. BALTZER, A. W., LIEBERMAN, J. R.: Regional gene therapy to enhance bone repair. Gene Ther., 11:344-350, 2004.
3. CARMODY, E. E., SCHWARZ, E. M., PUZAS, J. E., ROSIER, R. N., O'KEEFE, R. J.: Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum., 46:1298-1308, 2002.
4. DJAPIC, T., KUSEC, V., JELIC, M., VUKICEVIC, S., PECINA, M.: Compressed homologous cancellous bone and bone morphogenetic protein (BMP)-7 or bone marrow accelerate healing of long-bone critical defects. Int. Orthop., 27:326-330, 2003.
5. EVANS, C. H., ROBBINS, P. D.: Possible orthopaedic applications of gene therapy. J. Bone Jt Surg., 77:1103-1114, 1995.
6. EVANS, C. H., ROBBFNS, R D., GHIVIZZANI, S. C., HERNDON, J. H., KANG, R., BAHNSON, A. B. et al.: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum. Gene Ther., 7:1261-1280, 1996.
7. EVANS, C. H., ROBBINS, P. D.: Gene therapy of arthritis. Intern Med., 38:233-239, 1999.
8. EVANS, C. H., GHIVIZZANI, S. C., HERNDON, J. H., WASKO, M.C., REINECKE, J., WEHLING, P., et al.: Clinical trials in the gene therapy of arthritis. Clin. Orthop., 379:S300-S307, 2000.
9. EVANS, C. H., GHIVIZZANI, S. C., ROBBINS, P. D.: Orthopaedic gene therapy. Clin. Orthop. Relat. Res., 429:316-329, 2004.
10. FERNANDES, J., TARDIF, G., MARTEL-PELLETIER, J., LASCAU-COMAN, V., DUPUIS, M., MOLDOVAN, F., et al.: In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthtitis progression. Amer. J. Pathol., 154:1159-1169, 1999.
11. FRANCESCHI, R. T., YANG, S., RUTHERFORD, R. B., KREBSBACH, P. H., ZHAO, M., WANG, D.: Gene therapy approaches for bone regeneration. Cells Tissues Organs., 176:95-108, 2004.
12. GELSE, K., VON DER MARK K., AIGNER, T., PARK, J., SCHNEIDER, H.: Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Ardnitis Rheum., 48:430-441, 2003.
13. GERICH, T. G., KANG, R., FU, F. H., ROBBINS, P. D., EVANS, C. H.: Gene transfer to the patellar tendon. Knee Surg. Sports Traumatol. Arthrosc., 5:118-123, 1997.
14. GOUZE, J. N., GOUZE, E., PALMER, G. D., LIEW, V. S., PASCHER, A., BETZ, O. B. et al.: A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer. Arthritis Res. Ther. Epub., 5:R301-309, 2003.
15. GRANDE, D. A., MASON, J., LIGHT, E., DINES, D.: Stem cells as platforms for delivery of genes to enhance cartilage repair. J. Bone Jt Surg., 85-A (suppl. 2):111-116, 2003.
16. GUNTHER, M., WAGNER, E., OGRIS, M.: Specific targets in tumor tissue for the delivery of therapeutic genes. Curr Med Chem AnTi-Canc Agents., 5:157-171, 2005.
17. HELM, G. A., ALDEN, T. D., BERES, E. J., HUDSON, S. B., DAS, S., ENGH, J. A. et al.: Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J. Neurosurg. Spine, 92:191-196, 2000.
18. HILDEBRAND, K. A., DEIE, M., ALLEN, C. R., SMITH, D. W., GEORGESCU, H. I., EVANS, C. H. et al.: Early expression of marker genes in the rabbit medial collateral and anterior cruciate ligaments: the use of different viral vectors and the effects of injury. J. Orthop. Res. 17:37-42, 1999.
19. JELIC, M., PECINA, M., HASPL, M., KOS, J., TAYLOR, K., MATICIC, D. et al.: Regeneration of articular cartilage chondral defects by osteogenic protein-1 (bone morphogenetic protein-7) in sheep. Growth Factors, 19:101-113, 2001.
20. KANG, J. D., GEORGESCU, H. I., MCINTYRE-LARKIN, L., STEFANOVIC-RACIC, M., DONALDSON, W. F. 3rd, EVANS, C. H.: Herniated lumbar intervertebral discs spontaneously produce matrix metaroproteinases, nitric oxide, interleukin-6, and prostagiandin E2. Spine, 21:271-277, 1996.
21. KANG, R., MARUI, T., GHIVIZZANI, S. C., NITA, I. M., GEORGESCU, H. I., SUH, J. K. et al.: Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis Cartilage, 5:139-143, 1997.
22. KIM, D. J., MOON, S. H., KIM, H., KWON, U. H., PARK, M. S., HAN, K. J. et al.: Bone motphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cers. Spine, 28:2679-2684, 2003.
23. KOOSTRA, N. A., VERMA, I. M.: Gene therapy with viral vectors. Ann. Rev. Pharmacol. Toxicol., 43:413-439, 2003.
24. KOSTENUIK, P. J., BOLON, B., MORONY, S., DARIS, M., GENG, Z., CARTER, C. et al.: Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in oyariectomized mice. Bone, 34:656-664, 2004.
25. LEE, D. K., CHOI, K. B., OH, I. S., SONG, S. U., HWANG, S., LIM, C. L. et al.: Continuous transforming growth factor beta1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation. Tissue Eng., 11:310-308, 2005.
26. LIEBERMAN, J. R., DALUISKI, A., STEVENSON, S., WU, L., MCALLISTER, R, LEE, Y. P. et al.: The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Jt Surg., 81-A: 905-917, 1999.
27. MADRY, H., CUCCHIARINI, M., KAUL, G., KOHN, D., TERWILLIGER, E. F., TRIPPEL, S. B.: Menisci are efficiently transduced by recombinant adeno-associated virus vectors in vitro and in vivo. Amer. J. Sports Med., 32:1860-1865, 2004.
28. MARTINEK, V., LATTERMAN, C., USAS, A., ABRAMOWITCH, S., WOO, S. L., FU, F. H. et al.: Enhancement of tendonbone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer: a histological and biomechanical study. J. Bone Jt Surg., 84-A:1123-1131, 2002.
29. MI, Z., GHIVIZZANI, S. C., LECHMAN, E., GLORIOSO, J. C., EVANS, C. H., ROBBINS, P. D.: Adenovirus-mediated gene transfer of insulin-like growth factor I stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum., 43:2563-2570, 2000.
30. MIHELIC, R., PECINA, M., JELIC, M., ZORICIC, S., KUSEC, V., SIMIC, P. et al.: Bone morphogenetic protein-7 (osteogenic protein-1) promotes tendon graft integration in anterior cruciate ligament reconstruction in sheep. Amer. J. Sports Med., 32:1619-1625, 2004.
31. NISHIDA, K., KANG, J. D., GILBERTSON, L. G., MOON, S. H., SUH, J.K., VOGT, M. T. et al.: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine, 24:2419-2425, 1999.
32. NISHIKAWA, M., HUANG, L.: Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Hum. Gene Ther., 12:861-879, 2001.
33. NITA, I., GHIVIZZANI, S. C., GALEA-LAURI, J., BANDARA, G., GEORGESCU, H. I., ROBBINS, P. D. et al.: Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum., 39:820-828, 1996.
34. PASCHER, A., PALMER, G. D., STEINERT, A., OLIGINO, T., GOUZE, E., GOUZE, J. N., et al.: Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther., 11:133-141, 2004.
35. PASCHER, A., STEINERT, A. F., PALMER, G. D., BETZ, O., GOUZE, J. N., GOUZE, E. et al.: Enhanced repair of the anterior cruciate ligament by in situ gene transfer: evaluation in an in vitro model. Mol. Ther., 10:327-336, 2004.
36. PAUL, R., HAYDON, R. C., CHENG, H., ISHIKAWA, A., NENADOVICH, N., JIANG, W. et al.: Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine, 28:755-763, 2003.
37. PECINA, M., JELIC, M., MARTINOVIC, S., HASPL, M., VUKICEVIC, S.: Articular cartilage repair: the role of bone morphogenetic proteins. Int. Orthop., 26:131-136, 2002.
38. PECINA, M., HASPL, M., JELIC, M., VUKICEVIC, S.: Repair of a resistant tibial non-union with a recombinant bone morphogenetic protein-7 (rh-BMP-7). Int. Orthop., 27:320-321, 2003.
39. PELINKOVIC, D., LEE, J. Y., ADACHI, N., FU, F. H., HUARD, J.: Muscle-based gene therapy and tissue engineering. Crit. Rev. Eukaryot Gene Expr., 11:121-129, 2001.
40. SHULER, F. D., GEORGESCU, H. I., NIYIBIZI, C., STUDER, R. K., MI, Z., JOHNSTONE, B. et al.: Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J. Orthop. Res., 18:585-592, 2000.
41. STEINERT, A. F., PALMER, G. D., EVANS, C. H.: Gene therapy in the musculoskeletal system. Curr. Opin. Orthop., 15:318-324, 2004.
42. TAKEGAMI, K., THONAR, E. J., AN, H. S., KAMADA, H., MASUDA, K.: Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine, 27:1318-1325, 2002.
43. TRIPPEL, S. B., GHIVIZZANI, S. C., NIXON, A. J.: Gene-based approaches for the repair of articular cartilage. Gene Ther., 11:351-359, 2004.
44. ULRICH-VINTHER, M., CARMODY, E. E., GOATER, J. J., S BALLE, K., O'KEEFE, R. J., SCHWARZ, E. M.: Recombinant adenoassociated virus-mediated osteoprotegerin gene therapy inhibits wear debris - induced osteolysis. J. Bone Jt Surg., 84-A: 1405-1412, 2002.
45. URIST, M.: Bone: formation by autoinduction. Science, 150:893-899, 1965.
46. van der LAAN, W. H., QUAX, P. H., SEEMAYER, C. A., HUISMAN, L. G., PIETERMAN, E. J., GRIMBERGEN, J. M. et al.: Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther., 10:234-242, 2003.
47. VAN DE LOO, F. A., VAN DEN BERG, W. B.: Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. Rheum. Dis. Clin. N. Amer., 28:127-149, 2002.
48. VUKICEVIC, S., STAVLJENIC, A., PECINA, M.: Discovery and clinical applications of bone morphogenetic proteins. Europ. J. Clin. Chem. Clin. Biochem., 33:661-671, 1995.
49. WALLACH, C. J., SOBAJIMA, S., WATANABE, Y., KIM, J. S., GEORGESCU, H. I., ROBBINS, P. et al.: Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteogiycans in cells from degenerated human intervertebral discs. Spine, 28:2331-2337, 2003.
50. WALTHER, W., STEIN, U.: Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs, 60:249-271, 2000.
51. WATANABE, S., IMAGAWA, T., BOIVIN, G. P., GAO, G., WILSON, J. M., HIRSCH, R.: Adeno associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. Mol. Ther., 2:147-152, 2000.
52. XIAO, X., LI, J., SAMULSKI, R. J.: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol., 70:8098-8108, 1996.
53. YANG, S. Y., MAYTON, L., WU, B., GOATER, J. J., SCHWARZ, E. M., WOOLEY, P. H.: Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum., 46:2514-2523, 2002.
54. ZHANG, X., MAO, Z., YU, C.: Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J. Orthop. Res., 22:742-750, 2004.